treatment

Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries
Babatunde Akinwunmi, Daniel Buchenberger, Jenny Scherzer, Martina Bode, Paolo Rizzini, Fabio Vecchio, Laetitia Roustand, Gaelle Nachbaur, Laurent Finkielsztejn, Vasiliki Chounta, Nicolas Van de Velde

Sexually Transmitted Infections Feb 2021, sextrans-2020-054648; DOI: 10.1136/sextrans-2020-054648
Oropharyngeal Chlamydia trachomatis in women; spontaneous clearance and cure after treatment (FemCure)
Nicole H T M Dukers-Muijrers, Petra Wolffs, Mayk Lucchesi, Hannelore M Götz, Henry De Vries, Maarten Schim van der Loeff, Sylvia M Bruisten, Christian J P A Hoebe

Sexually Transmitted Infections Mar 2021, 97 (2) 147-151; DOI: 10.1136/sextrans-2020-054558
Spontaneous clearance of genital and extragenital Neisseria gonorrhoeae: data from GToG
Sarah Mensforth, Oluseyi Cyril Ayinde, Jonathan Ross

Sexually Transmitted Infections Dec 2020, 96 (8) 556-561; DOI: 10.1136/sextrans-2020-054500
HIV treatment cascade for older adults in rural South Africa
Julia K Rohr, Jennifer Manne-Goehler, Francesc Xavier Gómez-Olivé, Ryan G Wagner, Molly Rosenberg, Pascal Geldsetzer, Chodziwadziwa Kabudula, Kathleen Kahn, Stephen Tollman, Till Bärnighausen, Joshua A Salomon

Sexually Transmitted Infections Jun 2020, 96 (4) 271-276; DOI: 10.1136/sextrans-2018-053925
Antimicrobial resistance in Neisseria gonorrhoeae isolates from foreign-born population in the European Gonococcal Antimicrobial Surveillance Programme
Cristina Hernando Rovirola, Gianfranco Spiteri, Meritxell Sabidó, Alexandra Montoliu, Victoria Gonzalez, Jordi Casabona, Michelle Jayne Cole, Teymur Noori, Magnus Unemo

Sexually Transmitted Infections May 2020, 96 (3) 204-210; DOI: 10.1136/sextrans-2018-053912
O06.1 Gentamicin for pharyngeal gonorrhea: a single-arm, non-blinded clinical trial
Lindley Barbee, Olusegun Soge, Jennifer Morgan, Angela Leclair, Tamara Bass, James Hughes, Matthew Golden

Sexually Transmitted Infections Jul 2019, 95 (Suppl 1) A49; DOI: 10.1136/sextrans-2019-sti.134
S17.2 Treatment of bacterial vaginosis: how, when and how much?
Caroline Mitchell

Sexually Transmitted Infections Jul 2019, 95 (Suppl 1) A28; DOI: 10.1136/sextrans-2019-sti.78
S17.4 Prematurity and STI – value of screening and treatment
Deborah Money

Sexually Transmitted Infections Jul 2019, 95 (Suppl 1) A28; DOI: 10.1136/sextrans-2019-sti.80
Impact of expedited partner therapy (EPT) implementation on chlamydia incidence in the USA
Okeoma Mmeje, Sarah Wallett, Giselle Kolenic, Jason Bell

Sexually Transmitted Infections Nov 2018, 94 (7) 545-547; DOI: 10.1136/sextrans-2016-052887
Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associatedwith non-compliant prescribing: findings form a cross-sectional study
Anna Tisler-Sala, Sven-Erik Ojavee, Anneli Uusküla

Sexually Transmitted Infections Jun 2018, 94 (4) 298-303; DOI: 10.1136/sextrans-2017-053247

Main menu

treatment

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

treatment

Pages